Fitxers

882646.pdf (1.07 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2023-05-12

Llicència de publicació

cc-by (c) Lazarus Jeffrey V. et al., 2023
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/219345

Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1038/s43856-023-00292-y

Resum

Background: COVID-19 has hindered hepatitis C virus (HCV) and HIV screening, particularly in marginalised groups, who have some of the highest rates of these conditions and lowest rates of COVID-19 vaccination. We assessed the acceptability of combining HCV testing with COVID-19 vaccination in a centre for addiction services (CAS) in Barcelona and a mobile testing unit (MTU) in Madrid, Spain. Methods: From 28/09/2021 to 30/06/2022, 187 adults from marginalised populations were offered HCV antibody (Ab) testing along with COVID-19 vaccination. If HCV Ab+, they were tested for HCV-RNA. MTU participants were also screened for HIV. HCV-RNA+ and HIV+ participants were offered treatment. Data were analysed descriptively. Results: Findings show how of the 86 CAS participants: 80 (93%) had been previously vaccinated for COVID-19, of whom 72 (90%) had the full first round schedule; none had a COVID-19 vaccine booster and all received a COVID-19 vaccine; 54 (62.8%) were tested for HCV Ab, of whom 17 (31.5%) were positive, of whom all were tested for HCV-RNA and none were positive. Of the 101 MTU participants: none had been vaccinated for COVID-19 and all received a COVID-19 vaccine; all were tested for HCV Ab and HIV and 15 (14.9%) and 9 (8.9%) were positive, respectively; of those HCV Ab+, 9 (60%) were HCV-RNA+, of whom 8 (88.9%) have started treatment; 5 (55.6%) of those HIV+ had abandoned antiretroviral therapy, of whom 3 (60%) have re-started it. Conclusions: The intervention was accepted by 54 (62.8%) CAS participants and all MTU participants and can be used in marginalised communities.

Matèries

Hepatitis C, Vacunació, Espanya, COVID-19

Matèries (anglès)

Hepatitis C, Vaccination, Spain, COVID-19

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (ISGlobal)

Citació

LAZARUS, Jeffrey V., et al. Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain. Communications medicine. 2023. Vol. 3, num. 1. ISSN 2730-664X. [consulted: 22 of May of 2026]. Available at: https://hdl.handle.net/2445/219345

Exportar metadades

JSON - METS

Compartir registre